# US 2025/0152529 A1 · Method of escalating sotalol hydrochloride dosing

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0152529 A1
- Document ID: US20250152529A1
- Status: Published application
- Kind: A1
- Application number: 19/019,556
- Filed: 2025-01-14
- Published: 2025-05-15
- Earliest claimed: 2020-03-10
- Assignees: AltaThera Pharmaceuticals LLC
- Applicants: AltaThera Pharmaceuticals LLC
- Inventors: John Charin Somberg; Brandon Ira Kashfian; Janos Molnar
- Web page: https://patentgrep.com/patent/US20250152529A1

## CPC

- A61K 31/18: Sulfonamides (compounds containing a para-N-benzene-sulfonyl-N- group A61K31/63)
- A61K 9/0019: {Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner (non-active ingredients are additionally classified in A61K47/00)}
- A61P 9/06: Antiarrhythmics
- A61K 9/0053: {Mouth and digestive tract, i.e. intraoral and peroral administration}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention provides novel methods of initiating and escalating sotalol hydrochloride in patients in need thereof.

## Claims

### Claim 1

A method of escalating sotalol hydrochloride, dosing comprising:
a. escalating an existing sotalol concentration of a subject to a higher level by administering an intravenous (IV) dose of 105 mg sotalol hydrochloride over a period of 1 hour to the subject, wherein the subject had symptomatic atrial fibrillation or atrial flutter and is currently in sinus rhythm; and
b. after completion of the IV dose, administering oral dosing of one or more oral dose of sotalol hydrochloride to the subject in an amount of 160 mg;
wherein the subject is discharged from the hospital 24 hours after IV initiation.

### Claim 2 (depends on 1)

The method of claim 1, wherein the oral dosing is initiated 4-12 hours after completion of the IV dose.

### Claim 3

(canceled)

### Claim 4 (depends on 1)

The method of claim 1, wherein the oral dosing is initiated 4-6 hours after completion of the IV dose.

### Claim 5 (depends on 1)

The method of claim 1, wherein the oral dosing is initiated 6-12 hours after completion of the IV dose.

### Claim 6 (depends on 2)

The method of claim 2, wherein one or more of the oral doses are administered at an interval of 12-48 hours from initiation of the oral dosing.

### Claim 7 (depends on 4)

The method of claim 4, wherein one or more of the oral doses are administered at an interval of 12-24 hours from initiation of the oral dosing.

### Claim 8 (depends on 5)

The method of claim 5, wherein one or more of the oral doses are administered at an interval of 24-48 hours from initiation of the oral dosing.

### Claim 9 (depends on 1)

The method of claim 1, wherein:
the oral dosing is initiated 4 hours after completion of the IV dose; and
one or more of the oral doses are administered at an interval of 12 hours from initiation of the oral dosing.

### Claim 10 (depends on 1)

The method of claim 1, wherein:
the oral dosing is initiated 6 hours after completion of the IV dose; and
one or more of the oral doses are administered at an interval of 24 hours from initiation of the oral dosing.

### Claim 11 (depends on 1)

The method of claim 1, wherein:
the oral dosing is initiated 12 hours after completion of the IV dose; and
one or more of the oral doses are administered at an interval of 48 hours from initiation of the oral dosing.

### Claim 12 (depends on 1)

The method of claim 1, wherein the subject is receiving 120 mg oral sotalol hydrochloride therapy and the IV dose is administered to escalate the existing sotalol concentration of the subject to a higher concentration before administering the 160 mg oral dose of sotalol hydrochloride.
